Spiriva Linked to Stroke Risk

Health regulators announced Tuesday that a widely marketed drug inhaler may increase the risk of stroke. The Food and Drug Administration said that although stroke risk associated with Pfizer Inc. and Boehringer Ingelheim Pharmaceutical Inc's lung drug Spiriva is not conclusive it was important to notify doctors and patients about potential problems. Spiriva, which is marketed in the United States by Pfizer, is used to treat breathing problems associated with chronic obstructive pulmonary disease. Catherine Larkin, Bloomberg 03/18/2008
Read Article

If you are looking for a Spiriva attorney , please call us at 713-523-0001.